Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without genetic Flt3 abnormalitiesBRUSERUD, Øystein; HOVLAND, Randi; WERGELAND, Line et al.Haematologica (Roma). 2003, Vol 88, Num 4, pp 416-428, issn 0390-6078, 13 p.Article

Co-administration of Flt-3 ligand counteracts the actions of thrombopoietin in myelosuppressed rhesus monkeysHARTONG, Simone C. C; NEELIS, Karen J; WAGEMAKER, Gerard et al.British journal of haematology. 2003, Vol 121, Num 2, pp 359-367, issn 0007-1048, 9 p.Article

Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administrationDE KRUIJF, Evert-Jan F. M; HAGOORT, Henny; VELDERS, Gerjo A et al.Haematologica (Roma). 2010, Vol 95, Num 7, pp 1061-1067, issn 0390-6078, 7 p.Article

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediatedDEMARIA, Sandra; NG, Bruce; DEVITT, Mary Louise et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 862-870, issn 0360-3016, 9 p.Article

Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesisNAKAMORI, Yoshiki; BING LIU; KATAYAMA, Naoyuki et al.British journal of haematology. 2012, Vol 157, Num 6, pp 674-686, issn 0007-1048, 13 p.Article

FLT3 inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer. CommentaryBROWN, P; SMALL, D; TALLEN, G et al.European journal of cancer (1990). 2004, Vol 40, Num 5, pp 707-724, issn 0959-8049, 18 p.Article

Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatmentLEE KIM SWEE; BOSCO, Nabil; MALISSEN, Bernard et al.Blood. 2009, Vol 113, Num 25, pp 6277-6287, issn 0006-4971, 11 p.Article

FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA VaccinesKREITER, Sebastian; DIKEN, Mustafa; SELMI, Abderraouf et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 19, pp 6132-6142, issn 0008-5472, 11 p.Article

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in miceJUAN XU; WENHUAN XU; XIA CHEN et al.Vaccine. 2008, Vol 26, Num 35, pp 4519-4525, issn 0264-410X, 7 p.Article

Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in miceROBINSON, S. N; CHAVEZ, J. M; PISAREV, V. M et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 5, pp 361-369, issn 0268-3369, 9 p.Article

Initial evaluation and follow-up of acute radiation syndrome in two patients from the Dakar accidentMARC BERTHO, Jean; ROY, Laurence; SOUIDI, Maamar et al.Biomarkers (London. Print). 2009, Vol 14, Num 2, pp 94-102, issn 1354-750X, 9 p.Article

Cancer gene therapy using in vivo electroporation of Flt3-ligandSHIMAO, Kazuya; TAKAYAMA, Takuya; ENOMOTO, Katsuhisa et al.International journal of oncology. 2005, Vol 27, Num 2, pp 457-463, issn 1019-6439, 7 p.Article

Synergistic protecting effect of cord blood CD34⁺ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated miceYONG ZHANG; GUO, Chaohua; HONGBIN ZHANG et al.International journal of hematology. 2009, Vol 90, Num 1, pp 64-73, issn 0925-5710, 10 p.Article

Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8⁺ T cells efficiently in cancer patientsDAVIS, Ian D; QIYUAN CHEN; DIMOPOULOS, Nektaria et al.Journal of immunotherapy (1997). 2006, Vol 29, Num 5, pp 499-511, issn 1524-9557, 13 p.Article

Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccinationBAATARJAV, Tselmeg; KATAOKA, Kosuke; GILBERT, Rebekah S et al.Vaccine. 2011, Vol 29, Num 34, pp 5747-5757, issn 0264-410X, 11 p.Article

A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynxKODAMA, Satoru; HIRANO, Takashi; NODA, Kenji et al.Vaccine. 2010, Vol 28, Num 13, pp 2510-2516, issn 0264-410X, 7 p.Article

Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted TumorsCURRAN, Michael A; ALLISON, James P.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7747-7755, issn 0008-5472, 9 p.Article

Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agentsFURUICHI, Yoshiyuki; GOI, Kumiko; XIAOCHUN ZHANG et al.Cancer research (Baltimore). 2007, Vol 67, Num 20, pp 9852-9861, issn 0008-5472, 10 p.Article

Effect of Fit3 ligand gene transfer in experimental pancreatic cancerRYSCHICH, E; HUSZTY, G; WENTZENSEN, N et al.International journal of colorectal disease (Print). 2007, Vol 22, Num 2, pp 215-223, issn 0179-1958, 9 p.Article

Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges : Myeloid biologySTERNBERG, David W; LICHT, Jonathan D.Current opinion in hematology. 2005, Vol 12, Num 1, pp 7-13, issn 1065-6251, 7 p.Article

Prediction of resistance to small molecule FLT3 inhibitors: Implications for molecularly targeted therapy of acute leukemiaCOOLS, Jan; MENTENS, Nicole; FURET, Pascal et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6385-6389, issn 0008-5472, 5 p.Article

FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesisJENSEN, Christina T; KHARAZI, Shabnam; BOIERS, Charlotta et al.Blood. 2008, Vol 112, Num 6, pp 2297-2304, issn 0006-4971, 8 p.Article

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemiaABU-DUHIER, F. M; GOODEVE, A. C; WILSON, G. A et al.British journal of haematology. 2001, Vol 113, Num 4, pp 983-988, issn 0007-1048Article

Expression of Flt3-ligand by the endothelial cellSOLANILLA, A; GROSSET, C; LEMERCIER, C et al.Leukemia. 2000, Vol 14, Num 1, pp 153-162, issn 0887-6924Article

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferationKHARAZI, Shabnam; MEAD, Adam J; RECKZEH, Kristian et al.Blood. 2011, Vol 118, Num 13, pp 3613-3621, issn 0006-4971, 9 p.Article